Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease
Clinical trial NCT06046248 · RECRUITING
Trial details
- NCT number
- NCT06046248
- Sponsor
- Northside Hospital, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-29
- Primary completion
- 2026-12-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.